Search Results - "Barnett, Anthony"

Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus by Tahrani, Abd A., Barnett, Anthony H., Bailey, Clifford J.

“…Key Points Greater understanding of the complex and multifactorial pathogenesis of type 2 diabetes mellitus (T2DM) has informed the development of several new…”
Get full text

Type 2 diabetes in adolescents and young adults by Lascar, Nadia, Brown, James, Pattison, Helen, Barnett, Anthony H, Bailey, Clifford J, Bellary, Srikanth

“…The prevalence of type 2 diabetes in adolescents and young adults is dramatically increasing. Similar to older-onset type 2 diabetes, the major predisposing…”
Get full text

Management of type 2 diabetes: new and future developments in treatment by Tahrani, Abd A, MD, Bailey, Clifford J, Prof, Del Prato, Stefano, MD, Barnett, Anthony H, Prof

“…Summary The increasing prevalence, variable pathogenesis, progressive natural history, and complications of type 2 diabetes emphasise the urgent need for new…”
Get full text

Glucokinase Activators for Type 2 Diabetes: Challenges and Future Developments by Toulis, Konstantinos A., Nirantharakumar, Krishnarajah, Pourzitaki, Chrysa, Barnett, Anthony H., Tahrani, Abd A.

“…Increased hepatic glucose output, the primary liver dysregulation associated with Type 2 diabetes mellitus (T2DM), is not directly or effectively targeted by…”
Get full text

Neural imaginaries at work: Exploring Australian addiction treatment providers’ selective representations of the brain in clinical practice by Barnett, Anthony I., Pickersgill, Martyn, Dilkes-Frayne, Ella, Carter, Adrian

“…Although addiction neuroscience hopes to uncover the neural basis of addiction and deliver a wide range of novel neuro-interventions to improve the treatment…”
Get full text

Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial by Barnett, Anthony H, Prof, Mithal, Ambrish, MD, Manassie, Jenny, BMedSc, Jones, Russell, MSc, Rattunde, Henning, MD, Woerle, Hans J, Prof, Broedl, Uli C, MD

“…Summary Background Diabetes is a leading cause of chronic kidney disease (CKD) worldwide. Optimum glycaemic control in patients with type 2 diabetes is…”
Get full text

Built environmental correlates of older adults' total physical activity and walking: a systematic review and meta-analysis by Barnett, David W, Barnett, Anthony, Nathan, Andrea, Van Cauwenberg, Jelle, Cerin, Ester

“…Identifying attributes of the built environment associated with health-enhancing levels of physical activity (PA) in older adults (≥65 years old) has the…”
Get full text

SGLT inhibitors in management of diabetes by Tahrani, Abd A, MD, Barnett, Anthony H, Prof, Bailey, Clifford J, Prof

“…Summary The two main sodium–glucose cotransporters (SGLTs), SGLT1 and SGLT2, provide new therapeutic targets to reduce hyperglycaemia in patients with…”
Get full text

Insulin icodec: evolution or revolution in diabetes therapy? by Bellary, Srikanth, Barnett, Anthony H

Get full text

Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin by Barnett, Anthony H., Charbonnel, Bernard, Donovan, Mark, Fleming, Douglas

“…Abstract Objective: To evaluate efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes (T2D) with inadequate glycemic control on…”
Get full text

Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial by Barnett, Anthony H, Prof, Huisman, Holger, MSc, Jones, Russell, MSc, von Eynatten, Maximilian, MD, Patel, Sanjay, MB ChB, Woerle, Hans-Juergen, MD

“…Summary Background A substantial proportion of patients with type 2 diabetes are elderly (≥65 years) but this group has been largely excluded from clinical…”
Get full text

Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study by Pratley, Richard E, Dr, Nauck, Michael A, Prof, Barnett, Anthony H, Prof, Feinglos, Mark N, MD, Ovalle, Fernando, MD, Harman-Boehm, Illana, MD, Ye, June, PhD, Scott, Rhona, BSc[Hons], Johnson, Susan, MD, Stewart, Murray, DM, Rosenstock, Julio, MD

“…Summary Background As new members of a drug class are developed, head-to-head trials are an important strategy to guide personalised treatment decisions. We…”
Get full text

Ultra-long-acting insulin: a new chapter in diabetes therapy? by Karamat, Muhammad Ali, Bellary, Srikanth, Barnett, Anthony H

Get full text

Future challenges and therapeutic opportunities in type 2 diabetes: Changing the paradigm of current therapy by Owens, David R., Monnier, Louis, Barnett, Anthony H.

“…Most algorithms for type 2 diabetes mellitus (T2DM) do not recommend treatment escalation until glycated haemoglobin (HbA1c) fails to reach the recommended…”
Get full text

Obstructive Sleep Apnea and Retinopathy in Patients with Type 2 Diabetes. A Longitudinal Study by Altaf, Quratul A, Dodson, Paul, Ali, Asad, Raymond, Neil T, Wharton, Helen, Fellows, Hannah, Hampshire-Bancroft, Rachel, Shah, Mirriam, Shepherd, Emma, Miah, Jamili, Barnett, Anthony H, Tahrani, Abd A

“…Obstructive sleep apnea (OSA) is associated with several pathophysiological deficits found in diabetic retinopathy (DR). Hence, it's plausible that OSA could…”
Get full text

Adherence patterns in patients with type 2 diabetes on basal insulin analogues: missed, mistimed and reduced doses by Brod, Meryl, Rana, Azhar, Barnett, Anthony H.

“…Abstract Objective: To describe basal insulin analogue dosing irregularities, the effect of these events on patient functioning, well-being and diabetes…”
Get full text

Future glucose-lowering drugs for type 2 diabetes by Bailey, Clifford J, Prof, Tahrani, Abd A, PhD, Barnett, Anthony H, Prof

“…Summary The multivariable and progressive natural history of type 2 diabetes limits the effectiveness of available glucose-lowering drugs. Constraints imposed…”
Get full text

SGLT2 inhibitors in older adults: overcoming the age barrier by Bellary, Srikanth, Barnett, Anthony H

Get full text

Drug and alcohol treatment providers’ views about the disease model of addiction and its impact on clinical practice: A systematic review by Barnett, Anthony I., Hall, Wayne, Fry, Craig L., Dilkes‐Frayne, Ella, Carter, Adrian

“…Issues Addiction treatment providers’ views about the disease model of addiction (DMA), and their contemporary views about the brain disease model of addiction…”
Get full text

Glycaemic control in type 2 diabetes: targets and new therapies by Tahrani, Abd A, Piya, Milan K, Kennedy, Amy, Barnett, Anthony H

“…Type 2 diabetes mellitus (T2DM) is a worldwide public health challenge. Despite the availability of many antidiabetes agents and pharmacotherapies targeting…”
Get full text